What Researchers Did
Researchers prospectively recruited 26 patients with acute central retinal artery occlusion (CRAO) who had symptom onset within 6 hours and failed initial bedside treatment to investigate prognostic factors for visual outcome after hyperbaric oxygen therapy (HBOT).
What They Found
Among 26 patients with a mean age of 67.5 years, the mean visual acuity improved by 0.48 logarithm of minimal angle of resolution (approximately 9 letters) after hyperbaric oxygen therapy. They found that a thinner 1-to-3 mm circular rim of central macular thickness (CMT) and a shorter perfusion delay on fluorescein angiography (FFA) were associated with better visual outcomes.
What This Means for Canadian Patients
This research suggests that certain eye parameters, like central macular thickness and perfusion delay, could help Canadian ophthalmologists identify patients with acute central retinal artery occlusion who are more likely to benefit from hyperbaric oxygen therapy. Such insights may aid in triaging patients for HBOT, potentially improving visual outcomes for those experiencing this sight-threatening condition.
Canadian Relevance
This study was not conducted in Canada and therefore has no direct Canadian connection.
Study Limitations
A key limitation of this study is its small sample size of 26 patients, which may limit the generalizability of the findings.